http://phys.org/ en-us Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine. The prognosis for nearly three-quarters of elderly patients on intensive chemotherapy for acute myeloid leukemia (AML) is poor, with a median survival of less than six months, according to a study published online today in Blood, the journal of the American Society of Hematology. AML is the most common form of acute leukemia among adults and is a rapidly growing cancer of the bone marrow that requires immediate treatment. The average age at diagnosis is 67, and more than 12,000 people will be diagnosed with AML this year (according to the National Cancer Institute). http://phys.org/news199615047.html Medicine & Health Thu, 29 Jul 2010 10:00:01 EST news199615047 (PhysOrg.com) -- It might seem, watching a cell dividing languidly under a microscope, that nature has a straight-forward game plan: an orderly progression of "first this, then that." But backstage, it's much more messy. http://phys.org/news195113622.html Medicine & Health Mon, 07 Jun 2010 08:20:01 EST news195113622 Researchers have identified a self-feeding "vicious circle" of molecules that keeps acute leukemia cells alive and growing and that drives the disease forward. http://phys.org/news190395813.html Medicine & Health Tue, 13 Apr 2010 16:44:18 EST news190395813 Although bone marrow transplants have long been standard for acute leukemia, current treatments still rely on exact matches between donor and patient. Now, scientists at the University of Perugia, Italy, and the Weizmann Institute of Science have improved on a method of transplanting bone marrow-based stem cells from a mismatched donor, making it safer for use when no exact match exists. They were invited to present their findings at the recent annual American Society of Hematology conference in New Orleans. http://phys.org/news179403234.html Medicine & Health Mon, 07 Dec 2009 10:14:40 EST news179403234 The risk of developing leukemia as a side effect of a drug for multiple sclerosis (MS) is higher than previously reported, according to a study to be presented as part of the Late-breaking Science Program at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 - May 2, 2009. http://phys.org/news160307791.html Medicine & Health Thu, 30 Apr 2009 11:00:07 EST news160307791 Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found a new drug that restricts the growth of neuroblastoma, a childhood brain cancer. The pre-clinical study was presented today in the plenary session at the 22nd annual meeting of the American Society of Pediatric Hematology/Oncology. http://phys.org/news159728519.html Medicine & Health Thu, 23 Apr 2009 18:03:17 EST news159728519